107 related articles for article (PubMed ID: 12168902)
1. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
Oshita F; Kameda Y; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Shotsu A; Fujita A; Arai H; Ito H; Nakayama H; Mitsuda A
Anticancer Res; 2002; 22(2B):1065-70. PubMed ID: 12168902
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
[TBL] [Abstract][Full Text] [Related]
3. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer.
Oshita F; Kameda Y; Hamanaka N; Saito H; Yamada K; Noda K; Mitsuda A
Am J Clin Oncol; 2004 Jun; 27(3):215-9. PubMed ID: 15170136
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer.
Chang MH; Lee K; Lee KY; Kim YS; Kim YK; Kang JH
APMIS; 2012 Jan; 120(1):28-38. PubMed ID: 22151306
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
6. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
[TBL] [Abstract][Full Text] [Related]
7. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N
Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534
[TBL] [Abstract][Full Text] [Related]
9. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
Oshita F; Sekiyama A; Suzuki R; Ikehara M; Yamada K; Saito H; Noda K; Miyagi Y
Oncol Rep; 2003; 10(1):105-8. PubMed ID: 12469153
[TBL] [Abstract][Full Text] [Related]
10. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
Ikehara M; Oshita F; Kameda Y; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A
Oncol Rep; 2002; 9(4):835-8. PubMed ID: 12066218
[TBL] [Abstract][Full Text] [Related]
11. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
12. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
[TBL] [Abstract][Full Text] [Related]
13. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of beta1 integrin expression in metastatic melanoma.
Vihinen P; Nikkola J; Vlaykova T; Hahka-Kemppinen M; Talve L; Heino J; Pyrhönen S
Melanoma Res; 2000 Jun; 10(3):243-51. PubMed ID: 10890378
[TBL] [Abstract][Full Text] [Related]
15. Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.
Sève P; Isaac S; Trédan O; Souquet PJ; Pachéco Y; Pérol M; Lafanéchère L; Penet A; Peiller EL; Dumontet C
Clin Cancer Res; 2005 Aug; 11(15):5481-6. PubMed ID: 16061864
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
17. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary.
Müller-Klingspor V; Hefler L; Obermair A; Kaider A; Breitenecker G; Leodolte S; Kohlberger P
Anticancer Res; 2001; 21(3C):2185-8. PubMed ID: 11501844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
